Halo Pharmaceutical Canada, Inc
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Canada
- Registered address
- 17800 Lapointe, Mirabel, QC J7J0W8, Canada (CAN)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 3009856628 · DUNS 250928632
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2023-02-17
- NAIDrug Quality Assurance2017-09-15
- NAIDrug Quality Assurance2015-11-05
- VAIDrug Quality Assurance2014-11-14
Drugs this plant is listed as making
5 distinct drugs across 5 products name this site in their FDA label.
- Betamethasone Dipropionate USP, 0.05%TruPharma LLC
- dapsoneCosette Pharmaceuticals, Inc.
- IndomethacinAmneal Pharmaceuticals NY LLC
- promethazine hydrochloridein shortageXttrium Laboratories, Inc.
- Promethazine Hydrochloride and Dextromethorphan HydrobromideXttrium Laboratories, Inc
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.